According to a new report by Univdatos Market Insights, The MENA Syringes & Cannula Market was valued at USD 1,505.79 million in the year 2023 and is expected to grow at a strong CAGR of around 7.29% during the forecast period. Owing to the aging population is more vulnerable to illnesses that require hospitalization and medical procedures that involve syringes and cannula. As per the United Nations Population Fund (UNFPA), in 2024, the United Arab Emirates is going through a demographic transition as the number of persons aged 60+ is expected to increase more than six-fold between 2020 - 2050 from about 311,000 (3.1% of the total population) to 2 million (19.7%). Adding to this, the increased rate of diabetes, cardiovascular diseases, and other chronic diseases led to other increased frequency of standard medical procedures. Furthermore, the use of devices like cannula for surgeries and treatments has increased as medical procedures have advanced.

For More Detailed Analysis in PDF Format, Visit- https://univdatos.com/reports/mena-syringes-cannula-market?popup=report-enquiry

The report suggests that Syringes & Cannula resources in the MENA region had a significant impact on the Syringes & Cannula industry in the MENA region. Some of how this impact has been felt include:

·       In April 2024: Medline announced it has entered into a definitive agreement to acquire Ecolab, Inc.'s global surgical solutions business, including the industry-leading Microtek product lines. Once closed, the acquisition will provide Medline with innovative sterile drape solutions for surgeons, patients, operating room equipment, and Ecolab’s fluid temperature management system.

·       In May 2023, Pfizer and Thermo Fisher Scientific Inc. announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East and Asia where advanced genomic testing has previously been limited or unavailable.

·       In February 2021, the Advanced Medical Technology Association (AdvaMed) inked a MoU, entering a formal relationship with MECOMED, MEA’s medical devices, imaging, and diagnostics trade association. The collaboration facilitated information sharing between both organizations and increased the ability to strengthen this market.

·       In May 2021, Medovate, a medical device manufacturer in the U.K., announced a partnership in the Middle East. The Cambridge-based specialist has teamed up with Kuwait’s Omneya Medical Co. to distribute its SAFIRA (SAFer Injection for Regional Anesthesia) device in the Gulf country.

Apart from this, in recent years, UAE has significant growth in MENA, and North Africa has enhanced the growth of the Syringes & Cannula industry:

The UAE is expected to grow with a significant CAGR during the forecast period (2024-2032). The market of syringes and cannula in UAE is consequently driven by government initiatives to enhance healthcare and construct better healthcare facilities. The current government’s investment in health under Vision 2021 has emphasized quality health facilities that depend majorly on medical disposables for the overall safe course of medical practice. For instance, in October 2022, the Ministry of Industry and Advanced Technology (MoIAT) announced the signing of a pair of MoU worth Dh 260 million (USD 7 million) between major pharmaceutical companies and medical devices companies in the United Arab Emirates. The UAE has a well-developed healthcare sector featuring modern hospitals and clinics generating demand for superior medical consumables like syringes and cannula. In addition, the UAE is one of the prominent medical tourism destinations in the region, hosting patients from all corners of the world and adding to the demand for medical devices and supplies.

Explore the Comprehensive Research Overview - https://univdatos.com/reports/mena-syringes-cannula-market

Related Reports:

Diabetic Foot Ulcer Market

Inflammatory Bowel Disease Market

Compounding Pharmacies Market

MENA Tissue Diagnostic Market

Colorectal Cancer Market

Conclusion

In conclusion, Syringes & Cannula market in the MENA region is anticipated to show considerable growth in the future due to strategic healthcare investments and increasing incidences of chronic diseases. It was found that technological factors are indeed crucial, of which the move towards safer and more efficient medical device is prominent. However, one of the major issues facing the market players is the operationalization of these diverse regulatory frameworks regarding renewable energy implementation within the different countries of the MENA region. Therefore, in the future, the focus must be on long-term development and marketing, investing in innovation and compliance to capture new opportunities and maintain the scale of competitiveness in this evolving and growing healthcare market.

Contact Us:

UnivDatos Market Insights

Contact Number - +19787330253

Email - contact@univdatos.com 

Website - www.univdatos.com

Linkedin- https://www.linkedin.com/company/univ-datos-market-insight/mycompany/